Insider trades
Roger Jeffs, Director of Axsome Therapeutics AXSM, has filed 1 purchase and 45 sales on the open market. Over the past 12 months that comes to a net sale of $29.3M. The latest trade was on 06/11.
Roger Jeffs
Director
- Company
- Axsome Therapeutics AXSM
- First filing
- 23/01/05
- Trades
- 89 trades
- Buys / sales
- 1 / 45
- 12-month net buying
- −$29.3M
- Last trade
- 06/11
Trading activity
Transactions
| Trade type | |||||||
|---|---|---|---|---|---|---|---|
AXSM | Open-market sale10b5-1 plan | 06/10–06/11 | 06/11 | 572 sh2 trades | $247.65avg. | $141,655.8 | −1.0% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 05/27 | 05/28 | 6,428 sh | $62.18 | $399,693.04 | −0.6% |
LQDA | Open-market sale10b5-1 plan | 05/21–05/26 | 05/26 | 75,000 sh3 trades | $61.01avg. | $4,575,750 | −6.7% |
LQDA | Open-market sale10b5-1 plan | 05/18–05/20 | 05/20 | 75,000 sh3 trades | $58.91avg. | $4,418,000 | −6.3% |
LQDA | Open-market sale10b5-1 plan | 05/13–05/15 | 05/15 | 75,000 sh3 trades | $57.32avg. | $4,298,750 | −5.9% |
LQDA | Open-market sale10b5-1 plan | 05/08–05/12 | 05/12 | 75,000 sh3 trades | $45.89avg. | $3,442,000 | −5.6% |
LQDA | Open-market sale10b5-1 plan | 05/05–05/07 | 05/07 | 75,000 sh3 trades | $40.99avg. | $3,074,250 | −5.3% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 04/17 | 04/21 | 18,839 sh | $40.60 | $764,863.4 | −1.3% |
LQDA | Open-market sale10b5-1 plan | 04/14–04/16 | 04/16 | 53,300 sh3 trades | $40.21avg. | $2,143,250 | −3.6% |
LQDA | Open-market sale10b5-1 plan | 04/10–04/13 | 04/14 | 54,177 sh2 trades | $39.06avg. | $2,116,279.24 | No record |
LiquidiaLQDA | Open-market sale10b5-1 plan | 04/09 | 04/13 | 25,000 sh | $40.12 | $1,003,000 | −1.6% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 01/12 | 01/13 | 66,610 sh | $37.43 | $2,493,212.3 | −6.0% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 25/10/13 | 25/10/15 | 20,261 sh | $23.41 | $474,310.01 | −1.9% |
| Open-market sale10b5-1 plan | 25/09/02 | 25/09/02 | 13,464 sh | $123.68 | $1,665,227.52 | −19.0% | |
AXSM | Open-market sale10b5-1 plan | 25/08/27–25/08/29 | 25/08/29 | 60,000 sh3 trades | $121.72avg. | $7,303,400 | −45.8% |
AXSM | Open-market sale10b5-1 plan | 25/08/22–25/08/26 | 25/08/26 | 36,694 sh2 trades | $120.05avg. | $4,405,215.52 | −21.9% |
LQDA | Open-market sale10b5-1 plan | 25/07/14 | 25/07/15 | 40,504 sh2 trades | $14.28avg. | $578,397.12 | −3.8% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 25/06/04 | 25/06/05 | 30,610 sh | $16.97 | $519,451.7 | −2.8% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 25/04/14 | 25/04/16 | 14,130 sh | $13.57 | $191,744.1 | −1.4% |
LiquidiaLQDA | Open-market sale10b5-1 plan | 25/01/14 | 25/01/14 | 22,343 sh | $11.78 | $263,200.54 | −2.1% |
